NBIO (Nascent Biotech) Days Payable: 0.00 (As of Jun. 2024)


What is Nascent Biotech Days Payable?

Nascent Biotech NBIO Days Payable is 0.00 as of Jun. 2024.

Nascent Biotech's average Accounts Payable for the three months ended in Jun. 2024 was $0.68 Mil. Nascent Biotech's Cost of Goods Sold for the three months ended in Jun. 2024 was $0.00 Mil.

The historical rank and industry rank for Nascent Biotech's Days Payable or its related term are showing as below:

NBIO's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Nascent Biotech's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00). stayed the same

Nascent Biotech Days Payable Historical Data

* Premium members only.

The historical data trend for Nascent Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nascent Biotech Days Payable Chart

Nascent Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Days Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nascent Biotech Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NBIO vs BTAX, PXMD, XSNX: Days Payable Comparison

For the Biotechnology subindustry, Nascent Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nascent Biotech Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nascent Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Nascent Biotech's Days Payable falls into.


Nascent Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Nascent Biotech's Days Payable for the fiscal year that ended in Mar. 2024 is calculated as

Days Payable (A: Mar. 2024 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2023 ) + Accounts Payable (A: Mar. 2024 )) / count ) / Cost of Goods Sold (A: Mar. 2024 )*Days in Period
=( (0.498 + 0.686) / 2 ) / 0*365
=0.592 / 0*365
=N/A

Nascent Biotech's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

Days Payable (Q: Jun. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2024 ) + Accounts Payable (Q: Jun. 2024 )) / count ) / Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=( (0.686 + 0.683) / 2 ) / 0*365 / 4
=0.6845 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Nascent Biotech (NBIO) has a Days Payable of 0.00 as of Jun. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nascent Biotech and its competitors.
Is Nascent Biotech's Days Payable too high?
Nascent Biotech's current Days Payable is 0.00.
How does Nascent Biotech's Days Payable compare to BTAX and PXMD?
Nascent Biotech's Days Payable of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 112.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nascent Biotech and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nascent Biotech's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nascent Biotech stock overvalued right now?
Nascent Biotech (NBIO) has a current Days Payable of 0.00. The current Days Payable is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nascent Biotech (NBIO), the current Days Payable is 0.00 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nascent Biotech Business Description

Address 631 US Hwy 1, Suite 407, N Palm Beach, FL, USA, 33408
Nascent Biotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is focused on the development and delivery of human antibodies and cytokine responses to the treatment of cancer. The company's products include Pritumumab, CLNH5, and MultiPharm. The company is engaged in the development of Pritumumab which would be used for the treatment of brain cancer and pancreatic cancer. The company is also exploring the use of Pritumumab against other viruses.